Faravel K, Jarlier M, Senesse P, Huteau M-E, Janiszewski C, Stoebner A, Boisselier P Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy. Integr Cancer Ther. 2023;22. doi:10.1177/15347354221147283
Shoji K, Bayet E, Leverrier-Penna S, Le Devedec D, Mallavialle A, Marionneau-Lambot S, Rambow F, Perret R, Joussaume A, Viel R, Fautrel A, Khammari A, Constantin B, Tartare-Deckert S, Penna A The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential. EMBO Rep. 2023-02-06. doi:10.15252/embr.202255069
Cusumano C, Deshayes E, Guiu B, De Meeus G, Carrère S, Bouillin A, Ilonca D, Éberlé M, Guillemard S, Fersing C, Sgarbura O, Quénet F Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?. Ann Transl Med. 2023;11(5):202. doi:10.21037/atm-22-3665
Cashin P, Esquivel J, Larsen S, Liauw W, Alzahrani N, Morris D, Kepenekian V, Sourrouille I, Tuech J-J, Ceribelli C, Doussot B, Sgarbura O, Glehen O, Fisher O Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study. EClinicalMedicine. 2023;55. doi:10.1016/j.eclinm.2022.101746
Noverraz F, Robin B, Passemard S, Fauvel B, Presumey J, Rigal E, Cookson A, Chopineau J, Martineau P, Villalba M, Jorgensen C, Aubert-Pouëssel A, Morille M, Gerber-Lemaire S Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody. Int J Pharm. 2023;630. doi:10.1016/j.ijpharm.2022.122463
Borg J-P, Colinge J, Ravel P Modular response analysis reformulated as a multilinear regression problem. Bioinformatics. 2023-04-06. doi:10.1093/bioinformatics/btad166
François-Martin H, Pistilli B, Levy C, Frenel J-S, Guiu S, Mouret-Reynier M-A, Mailliez A, Eymard J-C, Petit T, Ung M, Desmoulins I, Augereau P, Bachelot T, Uwer L, Debled M, Ferrero J-M, Clatot F, Goncalves A, Chabaud S, Cottu P Long-Term Results with Everolimus in Advanced Hormone Receptor Positive Breast Cancer in a Multicenter National Real-World Observational Study. Cancers (Basel). 2023;15(4):1191. doi:10.3390/cancers15041191
Cassese G, Troisi R, Khayat S, Benoudifa B, Guiu B, Panaro F Liver Venous Deprivation Versus Portal Vein Embolization Before Major Hepatectomy for Colorectal Liver Metastases: A Retrospective Comparison of Short- and Medium-Term Outcomes. J Gastrointest Surg. 2023;27(2):296-305. doi:10.1007/s11605-022-05551-2
Villemin J-P, Bassaganyas L, Pourquier D, Boissière F, Cabello-Aguilar S, Crapez E, Tanos R, Cornillot E, Turtoi A, Colinge J Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR. Nucleic Acids Res. 2023-05-05. doi:10.1093/nar/gkad352
Dumet C, Pugnière M, Henriquet C, Gouilleux-Gruart V, Poupon A, Watier H Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods. Int J Mol Sci. 2023;24(6):5724. doi:10.3390/ijms24065724
Sauer L, Canovas R, Roche D, Shams-Eldin H, Ravel P, Colinge J, Schwarz R, Ben Mamoun C, Rivals E, Cornillot E FT-GPI, a highly sensitive and accurate predictor of GPI-anchored proteins, reveals the composition and evolution of the GPI proteome in Plasmodium species. Malar J. 2023;22(1):27. doi:10.1186/s12936-022-04430-0
Rabia E, Garambois V, Dhommée C, Larbouret C, Lajoie L, Buscail Y, Jimenez-Dominguez G, Choblet-Thery S, Liaudet-Coopman E, Cerutti M, Jarlier M, Ravel P, Gros L, Pirot N, Thibault G, Zhukovsky E, Gérard P-E, Pèlegrin A, Colinge J, Chardès T Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer. Front Immunol. 2023;14. doi:10.3389/fimmu.2023.1168444
Azari F, Meijer R, Kennedy G, Hanna A, Chang A, Nadeem B, Din A, Pèlegrin A, Framery B, Cailler F, Sullivan N, Kucharczuk J, Martin L, Vahrmeijer A, Singhal S Carcinoembryonic Antigen - Related Cell Adhesion Molecule Type 5 Receptor - Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer: A Nonrandomized Controlled Trial. JAMA Netw Open. 2023;6(1):e2252885. doi:10.1001/jamanetworkopen.2022.52885
Tassou A, Thouaye M, Gilabert D, Jouvenel A, Leyris J-P, Sonrier C, Diouloufet L, Mechaly I, Mallié S, Bertin J, Chentouf M, Neiveyans M, Pugnière M, Martineau P, Robert B, Capdevila X, Valmier J, Rivat C Activation of neuronal FLT3 promotes exaggerated sensorial and emotional pain-related behaviors facilitating the transition from acute to chronic pain. Prog Neurobiol. 2023;222. doi:10.1016/j.pneurobio.2023.102405
Schatz M, Marty L, Ounadjela C, Tong P, Cardace I, Mettling C, Milhiet P-E, Costa L, Godefroy C, Pugnière M, Guichou J-F, Mesnard J-M, Blaise M, Beaumelle B A Tripartite Complex HIV-1 Tat-Cyclophilin A-Capsid Protein Enables Tat Encapsidation That Is Required for HIV-1 Infectivity. J Virol. 2023;97(4):e0027823. doi:10.1128/jvi.00278-23
Antunes A, Alvarez-Vallina L, Bertoglio F, Bouquin N, Cornen S, Duffieux F, Ferré P, Gillet R, Jorgensen C, Leick M, Maillère B, Negre H, Pelegrin M, Poirier N, Reusch D, Robert B, Serre G, Vicari A, Villalba M, Volpers C, Vuddamalay G, Watier H, Wurch T, Zabeau L, Zielonka S, Zhang B, Beck A, Martineau P 10th antibody industrial symposium: new developments in antibody and adoptive cell therapies. MAbs. 2023;15(1):2211692. doi:10.1080/19420862.2023.2211692
Dahmani C, Corre E, Dandou S, Mangé A, Radulescu O, Coopman P, Cuq P, Larive R [Resistance to BRAF inhibitors: A lesson from clinical observations]. Med Sci (Paris). 2022;38(6-7):570-578. doi:10.1051/medsci/2022083
Houédé N, Pourquier P [Molecular signatures in castration-resistant prostate cancers: An update]. Bull Cancer. 2022-07-21. doi:10.1016/j.bulcan.2022.06.007
Houédé N, Flahault C, Gross-Goupil M, Le Clanche S, Le Goff Y, Merlier F, Pignot G, Pourroy B, Thibault C, Xylinas E, Solbes M-N, Dénéchère G [Locally advanced or metastatic bladder cancer: Identification of barriers and levers of patients' pathway in France]. Bull Cancer. 2022-06-17. doi:10.1016/j.bulcan.2022.04.010
Rollin P, Xylinas E, Lanz C, Audenet F, Brunelle S, Masson-Lecomte A, Pignot G, Roumiguié M, Méjean A, Neuzillet Y [Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie]. Prog Urol. 2022;32(5):326-331. doi:10.1016/j.purol.2021.12.008
Assenat E, Payen L, Mazard T, Glehen O, Calattini S, Villeneuve L, Lescuyer G, Vire B, Ychou M [hPG80 and cancer: A new blood biomarker in development for patient monitoring]. Bull Cancer. 2022;109(6):707-713. doi:10.1016/j.bulcan.2022.03.009
Maran-Gonzalez A [Histoseminar: Saved by a positive staining! About the use of diagnostic biomarkers in breast pathology: case no. 6]. Ann Pathol. 2022;42(4):317-324. doi:10.1016/j.annpat.2022.01.009
Legouté F, Lesueur P, El Kabbaj O, Ghannam Y, Michalet M, Monpetit E, Azria D, Giraud P, Calais G, Pointreau Y, Ollivier L [French careers in oncology radiotherapy: Crossing views]. Cancer Radiother. 2022-08-22. doi:10.1016/j.canrad.2022.07.016
Rousseau A, Laune Q, Ollivier L, Naoun N, Alexandre J, Giraud P, Azria D, Delaye M [Formation of French oncology resident: A national survey]. Bull Cancer. 2022;109(7-8):834-843. doi:10.1016/j.bulcan.2022.04.004
Cuenant A, Eglin I, Ferreira V, Houédé N [Development of a therapeutic education program for prostate cancer patients undergoing new generation hormone therapy]. Bull Cancer. 2022;109(5):623-629. doi:10.1016/j.bulcan.2021.11.014
Institut de Recherche en Cancérologie de
